Vital Images inks deal with Toshiba

Article

Medical imaging software firm Vital Images has entered into a marketing and distribution agreement with the medical systems

Medical imaging software firm Vital Images has entered into a marketing and distribution agreement with the medical systems unit of Toshiba, headquartered in Tochigi, Japan. The deal calls for Toshiba to offer Vital Images' Vitrea 2 software through its subsidiaries and distributors in more than 50 countries in North and South America, Europe, the Middle East, Africa, Australia, and Asia, excepting Japan. The agreement also supersedes and extends Vital Images' current marketing and distribution arrangement with Toshiba America Medical Systems (TAMS), Toshiba's U.S. subsidiary. Since October 2000, TAMS has offered Vitrea 2 systems as the 3D medical imaging product of choice to customers purchasing Aquilion CT scanners. Initially, TAMS purchased the hardware platform as well as software and services.

The new agreement covers only higher margin software and services and includes a minimum worldwide revenue commitment of $4 million. The agreement is retroactive to Oct. 1, 2001, and will be effective through Sept. 30, 2002. It can be extended by mutual consent of Vital Images and Toshiba.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.